Trial Profile
Eculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated Atypical Hemolytic Uremic Syndrome: A Case Series
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2023
Price :
$35
*
At a glance
- Drugs Eculizumab (Primary)
- Indications Haemolytic uraemic syndrome
- Focus Therapeutic Use
- 30 May 2020 Planned End Date changed from 15 Dec 2018 to 30 Nov 2020.
- 30 May 2020 Planned primary completion date changed from 15 Sep 2018 to 30 Aug 2020.
- 06 Jul 2018 Planned End Date changed from 15 Oct 2018 to 15 Dec 2018.